Multinational pharma companies appear set to continue ceding the dominant positions of their off-patent drugs in the pharmacies of Chinese public hospitals, as they emerged battered from the seventh round of China’s national tender program for generic medicines.
While foreign drug makers currently hold the leading domestic market share for roughly 40% of the 61 generics targeted in...